Neal J. Meropol is a medical oncologist, clinical investigator and health outcomes researcher who serves as vice president of research oncology at Flatiron Health. In this role, he leads efforts to leverage Flatiron’s technology platforms and nationwide provider network to gain insights from real-world data that accelerate research and improve quality of care for cancer patients. Prior to joining Flatiron, Neal was professor and chief of the division of hematology and oncology at University Hospitals Cleveland Medical Center and Case Western Reserve University, and associate director for clinical research at the Case Comprehensive Cancer Center.
Dr. Meropol’s research contributions include clinical trials and health outcomes research, including evaluation of new agents, predictors of response and outcome, studies of clinical decision making, and assessment of the economic impact of care. He previously served as chair of the National Cancer Institute Gastrointestinal Cancer Steering Committee, and currently serves on the NCI Clinical Trials and Translational Research Advisory Committee (CTAC). Dr. Meropol also completed a four-year term as an elected member of the American Society of Clinical Oncology Board of Directors. He has authored more than 250 manuscripts, book chapters, and editorials related to cancer prevention, treatment, decision making, and health economics.
Dr. Meropol received his undergraduate degree in philosophy from Princeton University and MD from Vanderbilt University. He was a resident in internal medicine at Case Western Reserve University, and completed hematology and medical oncology fellowships at the University of Pennsylvania. He spent a sabbatical at the Leonard Davis Institute of Health Economics at the Wharton School of the University of Pennsylvania.
3:45 PM–4:45 PM May 20, 2019
Room 388-390 (3rd fl)